In the wake of 23andMe's big data breach and major layoffs, are you looking to get your genetic info out of the company's ...

Shelby Brown (she/her/hers) is an editor for CNET's services team. She covers tips and tricks for apps, operating systems and devices, as well as mobile gaming and Apple Arcade news. Shelby also ...

The biggest stories of the day delivered to your inbox.

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.

23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company's stock hit a rock-bottom of US$0.30, down 96 ...

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...